MOODS-12312: a novel risk score to identify patients with atrial fibrillation and significant sleep-disordered breathing

17 March 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Kadhim Kadhim

University of Adelaide, Adelaide (Australia)

20 More presentations in this session

Presentation thumbnail

Validation of the mb-later score for predicting atrial fibrillation occurrence after catheter-ablation of typical atrial flutter

Doctor M. Marinkovic (Belgrade, RS)

Presentation thumbnail

Cardiac resynchronization therapy in diabetic patients improves survival in the group of patients with atrial fibrillation in the first twelve years. Long term follow-up.

Doctor R. Ramirez Rodriguez (Las Palmas de Gran Canaria, ES)

Presentation thumbnail

Disparity between subjective and objective sleep-related measures in patients with concomitant sleep-disordered breathing and atrial fibrillation

Doctor K. Kadhim (Adelaide, AU)

Presentation thumbnail

Levels of anxiety in patients with persistent atrial fibrillation undergoing elective cardioversion: does the type of anticoagulation matter?

Doctor E. Garcia-Izquierdo Jaen (Majadahonda, ES)

Abstract Slides

Presentation thumbnail

Atrial appendage mechanics and superior vena cava area assessed by transoesophageal echocardiography in prediction of atrial fibrillation recurrence after pulmonary vein isolation

Doctor I. Zeljkovic (Zagreb, HR)

Access the full session

Session thumbnail

Poster session 2 - Atrial Fibrillation - Clinical

The Event

EHRA 2019

17 March - 19 March 2019

You may be interested in

Congress Presentation

Interactive discussion and Q&A

Congress Presentation

Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion

Congress Presentation

Oral anticoagulation in subclinical atrial fibrillation: pro

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources